Tigecycline-induced acute pancreatitis: case report and literature review

被引:44
作者
Hung, Whitney Y. [1 ]
Kogelman, Laura [2 ]
Volpe, Gretchen [2 ]
Iafrati, Mark [3 ]
Davidson, Lisa [2 ]
机构
[1] Tufts Med Ctr 420, Dept Pharm, Boston, MA 02111 USA
[2] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA
[3] Tufts Med Ctr, Div Vasc Surg, Boston, MA 02111 USA
关键词
Tigecycline; Pancreatitis; Adverse drug reaction; DRUG; EFFICACY; PHASE-3; SAFETY;
D O I
10.1016/j.ijantimicag.2009.05.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Tigecycline is a broad-spectrum antimicrobial agent structurally related to minocycline. Pancreatitis has been associated with the tetracycline class of antibiotics and concerns about tigecycline-induced acute pancreatitis have recently been raised. We describe a 69-year-old female who received tigecycline for treatment of a complicated skin and skin-structure infection. Following 7 days of tigecycline she developed severe abdominal pain and elevated pancreatic enzymes suggesting acute pancreatitis. According to the Naranjo adverse drug reaction probability scale, tigecycline was the probable cause of her acute pancreatitis. Clinicians should be aware of this potential adverse effect of tigecycline. We recommend that clinicians monitor patients for signs and symptoms of pancreatitis, including abdominal pain, during treatment with tigecycline. (C) 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:486 / 489
页数:4
相关论文
共 15 条
[1]   Drug-Induced Pancreatitis Incidence, Management and Prevention [J].
Balani, Anil R. ;
Grendell, James H. .
DRUG SAFETY, 2008, 31 (10) :823-837
[2]   Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin [J].
Bergallo, Carlos ;
Jasovich, Abet ;
Teglia, Osvaldo ;
Eugenia Oliva, Maria ;
Lentnek, Arnold ;
de Wouters, Luisa ;
Zlocowski, Juan Carlos ;
Dukart, Gary ;
Cooper, Angel ;
Mallick, Rajiv .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 63 (01) :52-61
[3]  
ELMORE MF, 1981, GASTROENTEROLOGY, V81, P1134
[4]   Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci:: a Phase 3, multicentre, double-blind, randomized study [J].
Florescu, I. ;
Beuran, A. ;
Dimov, R. ;
Razbadauskas, A. ;
Bochan, M. ;
Fichev, G. ;
Dukart, G. ;
Babinchak, T. ;
Cooper, C. A. ;
Ellis-Grosse, E. J. ;
Dartois, N. ;
Gandjini, H. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 :I17-I28
[5]   Acute pancreatitis related to tigecycline: Case report and review of the literature [J].
Gilson, Melanie ;
Moachon, Laurence ;
Jeanne, Luc ;
Dumaine, Valerie ;
Eyrolle, Luc ;
Morand, Philippe ;
Ben M'Rad, Mona ;
Salmon, Dominique .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (08) :681-683
[6]   FATTY LIVER OF PREGNANCY AND ITS RELATIONSHIP TO TETRACYCLINE THERAPY [J].
KUNELIS, CT ;
PETERS, JL ;
EDMONDSON, HA .
AMERICAN JOURNAL OF MEDICINE, 1965, 38 (03) :359-+
[7]   Tigecycline-induced Pancreatitis [J].
Lipshitz, Jay ;
Kruh, Jonathan ;
Cheung, Philip ;
Cassagnol, Manouchkathe .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (01) :93-93
[8]  
MACDONALD H, 1973, CLIN PHARMACOL THER, V14, P852
[9]  
Marshall SR, 2009, HOSP PHARM, V44, P239, DOI 10.1310/hpj4403-239
[10]   ADVANCES IN THE DIAGNOSIS OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
SHEAR, NH ;
LANCTOT, KL .
JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (10) :897-904